Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #35612 on Revive Therapeutics Ltd (RVVTF)
Hotel Delta
05/04/23 7:54 AM
#35613 RE: Classic Warrior #35612
Gatorca
05/04/23 10:57 AM
#35614 RE: Classic Warrior #35612
Bucillamine Phase 3 clinical trial (NCT04504734) for #COVID-19 💊By Revive Therapeutics $RVV $RVVTF▪️DSMB meeting on May 10th, 2023 and will assess the efficacy of Bucillamine▪️Revive expects to announce the recommendation of the DSMB meeting by May 17th, 2023.$veru $pfe pic.twitter.com/sP6M9RSec7— BITCOIN | DATA | LONG COVID (@kamtraders) May 4, 2023
Bucillamine Phase 3 clinical trial (NCT04504734) for #COVID-19 💊By Revive Therapeutics $RVV $RVVTF▪️DSMB meeting on May 10th, 2023 and will assess the efficacy of Bucillamine▪️Revive expects to announce the recommendation of the DSMB meeting by May 17th, 2023.$veru $pfe pic.twitter.com/sP6M9RSec7
medicinecat
05/04/23 7:38 PM
#35618 RE: Classic Warrior #35612